Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
MMWR. Morbidity and Mortality Weekly Report|December 21, 2023
Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, December 2023Hannah E Reses, Heather Dubendris, Lori Haas, et al.
MMWR. Morbidity and Mortality Weekly Report|April 3, 2025
Epidemiology of Symptomatic Human Metapneumovirus Infection in the CASCADIA Community-Based Cohort - Oregon and Washington, 2022-2024Mila Shakya, Helen Y Chu, Janet A Englund, et al.
The American Journal of Tropical Medicine and Hygiene|August 14, 2019
Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood <i>Schistosoma mansoni</i>-Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the Lake Victoria Regions of Kenya and TanzaniaYe Shen, Ryan E Wiegand, Annette Olsen, et al.
Plos One|December 9, 2022
Impact of the COVID-19 Vaccination Program on case incidence, emergency department visits, and hospital admissions among children aged 5-17 Years during the Delta and Omicron Periods-United States, December 2020 to April 2022Katherine G Topf, Michael Sheppard, Grace E Marx, et al.
The Journal of Infectious Diseases|January 8, 2015
The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant WomenJulie Gutman, Linda Kalilani, Steve Taylor, et al.
MMWR. Morbidity and Mortality Weekly Report|February 2, 2023
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, et al.
The American Journal of Tropical Medicine and Hygiene|May 14, 2020
SCORE Studies on the Impact of Drug Treatment on Morbidity due to <i>Schistosoma mansoni</i> and <i>Schistosoma haematobium</i> InfectionCharles H King, Sue Binder, Ye Shen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 7, 2023
Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period-United States, 1 January 2022 to 31 March 2022Lyudmyla Kompaniyets, Ryan E Wiegand, Adewole C Oyalowo, et al.
Plos Neglected Tropical Diseases|June 9, 2020
Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community studyChristine L Dubray, Anita D Sircar, Valery Madsen Beau de Rochars, et al.
Food Control|May 27, 2024
Low prevalence of viable <i>Toxoplasma gondii</i> in fresh, unfrozen American pasture-raised pork and lamb from retail meat stores in the United StatesJitender P Dubey, Dolores E Hill, Valsin Fournet, et al.
Pageof 13